El sexo es esa palabra que puede significar y sentirse de forma tan diferente dependiendo del contexto de nuestras vidas. Como jóvenes adolescentes, la palabra puede llenarnos de una sensación de intriga y excitación; como adultos que martillean por la vida, algunos de nosotros pueden encontrarlo como una fuente de placer mientras que otros pueden utilizarlo para fomentar el significado de una relación, y para algunos de nosotros puede servir como un medio para producir hijos. Aunque el...

CLICK HERE TO WATCH THE EVENT ONDEMAND The 2022 English Targeted Therapies Patient Forums is Now Over. For further detail, please click here.

GRACE is pleased to announce the acceptance of four rising stars into the 4th year of the GRACE Patient Education Ambassadors Program for the 2022-23 Program Year! All four candidates have shown a genuine passion for patient education and innovation in connecting with the patient community. The program will encompass the participants creating content that will be featured on the GRACE website, working alongside GRACE faculty, Board and staff, and learning the most current and effective...

We are excited to launch our second year of this program - Patient Perspectives - Clinical Trials Experiences Through Storytelling GRACE’s mission is to provide expert-mediated information directly to cancer patients and their caregivers to empower them to become direct partners in their cancer treatment. The Clinical Trials Experiences Through Storytelling program helps patients to become educators and to help others learn about the journey they may be beginning or continuing on. To apply...

Join us on SATURDAY, JULY 16th, 2022, for the 2022 Targeted Therapies Patient Forum This virtual program is presented Live Online from 10 AM - 4 PM EST Register Now! In this 8th annual live patient forum, leading thoracic oncologists from around the world as well as lung cancer patients who are active within the patient advocacy community discuss subjects relevant to all targets as well as breakout sessions on rare mutations. This 6-hour live virtual webinar is an opportunity for lung cancer...

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this final video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma shares the milestones she has reached, and personal information about the important time that she has been given...

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma discusses lifting the barriers to entry and acceptance into a clinical trial. Many thanks to our sponsors! #Exelixis...

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video, Melinda Bachini, a 12-year survivor discusses her next steps and finding a clinical trial for cholangiocarcinoma. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly To...

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this first video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma discusses her diagnosis and her next steps for dealing with the treatment of this rare cancer. Many thanks to our...